By selecting only a few key psoriasis signature genes, there was a non‐significant trend towards an increased disease activity in skin at relapse compared with that of baseline LS (Figure 1C), including IL‐17, IL‐23, IL‐36 and TNF signalling, which are known to be heavily involved in the pathogenesis of psoriasis. The gene discussed is IL17A; the disease is psoriasis.